134 science jobs found in Chantilly, VA

Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 145-year-old global pharmaceutical company with headquarters in Osaka, Japan.

Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 145-year-old global pharmaceutical company with headquarters in Osaka, Japan.

Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 145-year-old global pharmaceutical company with headquarters in Osaka, Japan.

Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 145-year-old global pharmaceutical company with headquarters in Osaka, Japan.

Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 145-year-old global pharmaceutical company with headquarters in Osaka, Japan.

Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 145-year-old global pharmaceutical company with headquarters in Osaka, Japan.

Our desire to make a positive impact on our patients extends to our employees and we are committed to fostering an inclusive environment where every person feels seen, valued, and heard – so employees can thrive in all areas of their lives, in and outside of work. 

Our desire to make a positive impact on our patients extends to our employees and we are committed to fostering an inclusive environment where every person feels seen, valued, and heard – so employees can thrive in all areas of their lives, in and outside of work. 

Our desire to make a positive impact on our patients extends to our employees and we are committed to fostering an inclusive environment where every person feels seen, valued, and heard – so employees can thrive in all areas of their lives, in and outside of work. 

Our desire to make a positive impact on our patients extends to our employees and we are committed to fostering an inclusive environment where every person feels seen, valued, and heard – so employees can thrive in all areas of their lives, in and outside of work. 

At Bayer, our largest segment in terms of sales, we focus on researching, developing and marketing specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. In this way, we are addressing the growing requirements of patients, physicians, health care payers and regulatory agencies.

Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 145-year-old global pharmaceutical company with headquarters in Osaka, Japan.

Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 145-year-old global pharmaceutical company with headquarters in Osaka, Japan.

At Mallinckrodt, we use strategic vision and employee-driven momentum to pursue a powerful mission: Managing Complexity. Improving Lives.

At Mallinckrodt, we use strategic vision and employee-driven momentum to pursue a powerful mission: Managing Complexity. Improving Lives.

We are a focused biopharma company. We prevent and treat disease with vaccines, specialty and general medicines. We focus on the science of the immune system and advanced technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/immunology and oncology).

We are a focused biopharma company. We prevent and treat disease with vaccines, specialty and general medicines. We focus on the science of the immune system and advanced technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/immunology and oncology).

We are a focused biopharma company. We prevent and treat disease with vaccines, specialty and general medicines. We focus on the science of the immune system and advanced technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/immunology and oncology).

We are a focused biopharma company. We prevent and treat disease with vaccines, specialty and general medicines. We focus on the science of the immune system and advanced technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/immunology and oncology).

We are a focused biopharma company. We prevent and treat disease with vaccines, specialty and general medicines. We focus on the science of the immune system and advanced technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/immunology and oncology).